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Induced pluripotency is a promising avenue for dis-
ease modeling and therapy, but the molecular princi-
ples underlying this process, particularly in human
cells, remain poorly understood due to donor-to-
donor variability and intercellular heterogeneity.
Here, we constructed and characterized a clonal,
inducible human reprogramming system that pro-
vides a reliable source of cells at any stage of the pro-
cess. This system enabled integrative transcriptional
and epigenomic analysis across the human reprog-
ramming timeline at high resolution. We observed
distinct waves of gene network activation, including
the ordered re-activation of broad developmental
regulators followed by early embryonic patterning
genes and culminating in the emergence of a signa-
ture reminiscent of pre-implantation stages. More-
over, complementary functional analyses allowed
us to identify and validate novel regulators of the re-
programming process. Altogether, this study sheds
light on the molecular underpinnings of induced plu-
ripotency in human cells and provides a robust cell
platform for further studies.
INTRODUCTION
Engineered reprogramming systems have provided useful tools
for the study of induced pluripotency. In ‘‘secondary’’ reprog-
ramming systems, somatic cells are first transduced with lentivi-
ral constructs carrying drug-inducible transcription factors.
Clonal induced pluripotent stem cells (IPSCs) are then derived
and next differentiated back to a somatic state that can be re-
programmed a second time, often with greater efficiency (Hock-
emeyer et al., 2008; Stadtfeld et al., 2010; Wernig et al., 2008).
Because the resulting somatic cells are clonal, this strategy elim-412 Cell 162, 412–424, July 16, 2015 ª2015 Elsevier Inc.inates biases and heterogeneity caused by variable lentiviral de-
livery and transgene stoichiometry present in ‘‘primary’’ reprog-
ramming experiments (Stadtfeld et al., 2010).
Secondary reprogramming systems engineered from trans-
genic mouse embryonic fibroblasts (MEFs) have enabled large-
scale genomic and epigenomic profiling studies of cells as
they reacquire pluripotency (Hussein et al., 2014; Mikkelsen
et al., 2008; Polo et al., 2012). These analyses have revealed
that somatic identity is rapidly lost upon induction of the reprog-
ramming factors and pluripotency is promoted by an early
mesenchymal to epithelial transition (MET) (Li et al., 2010), a pro-
cess accompanied by removal of several epigenetic roadblocks
(Apostolou and Hochedlinger, 2013). It has, however, been diffi-
cult to directly compare the reprogramming MEFs to the same
process in human cells, due to differences in culture conditions,
differential expression of key markers, and other factors. Under
standard conditions, murine IPSCs also appear to reprogram
with faster kinetics and higher efficiency than human IPSCs
and reach a more naive, pre-implantation-like cellular state
(Hanna et al., 2010; Nichols and Smith, 2009). Moreover, ana-
lyses of intermediate states in previous systems have been
complicated by heterogeneity in the initial cell populations and
progressive loss of reprogramming capacity over serial
passaging (Utikal et al., 2009). Thus, awell-controlledmodel sys-
tem that generates intermediately and fully reprogrammed cells
with consistent kinetics and efficiency even after extensive
expansion in vitro would be a valuable asset for efforts to char-
acterize reprogramming in human cells.
We hypothesized that senescence would be a major contrib-
utor to the variability and passage-dependent loss of reprogram-
ming capacity that has been observed in previous attempts to
generate human reprogramming systems (Park et al., 2008).
We therefore sought to extend the lifespan of human secondary
fibroblasts by overexpression of the telomerase gene (hTERT).
Here, we employ this approach to generate a robust model sys-
tem that enables continual propagation of clonal cells with a
defined reprogramming capacity. We leverage this model to sys-
tematically characterize the transcriptional and epigenomic
changes during reprogramming. Through integrative analyses,
we find that OCT4/KLF4/c-MYC/SOX2 (OKMS) induction leads
to transient reactivation of genes in a pattern that is suggestive of
a reversal of normal development. Unexpectedly, these changes
culminate in the emergence of a subpopulation of cells with tran-
scriptional and epigenomic signatures with pre-implantation-like
characteristics. Finally, we demonstrate the utility of our second-
ary system for discovery and characterization of a variety of
modulators of reprogramming in human cells.
RESULTS
hTERT Confers Robustness to Secondary
Reprogramming Systems
We generated human IPSCs (hIPSCs) from primary BJ foreskin
fibroblasts using a doxycycline (DOX)-inducible, polycistronic
human OCT4/KLF4/c-MYC/SOX2 (OKMS) cassette. We then
differentiated these hIPSCs in a serum-based media (Park
et al., 2008) to obtain human inducible fibroblasts-like cells
(hiF) that could be subsequently reprogrammed by DOX treat-
ment (Figure 1A). Consistent with previous attempts, both pri-
mary BJ cells and secondary hiF generated IPSC colonies that
were highly heterogeneous in size and appeared asynchronously
over 3 weeks following OKMS induction (Figure 1B). Moreover,
secondary hiFs rapidly lost their reprogramming potential with
successive passages in culture, which correlated with the
appearance of senescent cells (Figure 1C). Foreskin fibroblasts
from different donors also displayed variability in proliferation
and senescence (Figures S1A–S1E), which influenced reprog-
ramming efficiencies in a passage-dependent manner (Fig-
ure S1F). We observed similar variability across different batches
of secondary cells generated from the same pluripotent stem cell
(PSC) clone (dH1f or hiF; Figures S1A–S1F). These observations
highlight the variable reprogramming efficiency of previous pri-
mary and secondary reprogramming systems.
To increase the expansion potential of hiF cells, we delivered a
lentiviral vector driving constitutive human telomerase (hTERT)
expression (Stewart et al., 2003) and derived clonal cell lines
(hiF-T; Figure 1A, lower scheme). Inclusion of hTERT in reprog-
ramming cocktails is known to be compatible with IPSC genera-
tion (Park et al., 2008). hiF-Ts displayed a lower reprogramming
efficiency than early passage hiFs. But unlike both hiF and pri-
mary cells, they showed no evidence of senescence and main-
tained a stable reprogramming efficiency even after 3 months
of continuous culture (Figure 1D; Figure S1F). At the same
time, hiF-Ts showed growth and apoptosis rates that were
equivalent to healthy primary cells and were negative in assays
of cellular transformation (Figures S1A–S1E). Thus, hTERT
expression also appears to reduce a key source of experimental
variability in reprogramming systems.
To better understand the differences between primary (BJ),
secondary (hIF), and secondary immortalized (hiF-T) reprogram-
ming systems, we performed expression profiling by RNA
sequencing (RNA-seq). We found that hiF cells downregulated
proliferative genes after only limited passaging, while hiF-Ts
maintained expression of these genes in long-term cultures
(Figure 1E). Moreover, hiF cultures expressed high levels of
genes associated with ‘‘stemness,’’ even after the emergenceof senescent cells, indicating either the persistence of primed
or privileged subpopulations or incomplete differentiation. Either
case might explain the high reprogramming efficiency of early
passage hiFs. In contrast, the stemness genes were silenced
in BJ and hiF-T cells. The consistency of hiF-T reprogramming
may therefore reflect hTERT’s ability to block senescence, but
may also ensure that the secondary cells can be cultured long
enough to acquire a fully differentiated state (Figure 1F).
Importantly, hiF-T cells showed high levels of genomic and
transcriptional stability (Figures S1G and S1H). Moreover, gene
expression profiles of hIPSCs derived from reprogrammed
hiF-T cells (hIPSC-T) are equivalent to reference PSCs, showing
expression of expected protein markers and complete silencing
of all transgenes, including hTERT (Figures S1I and S2). hIPSC-
Ts also maintain the capacity to form all three embryonic germ
layers in vitro through directed differentiation (Figures S1J and
S1K). We therefore conclude that hIF-T secondary cells provide
a faithful and reliable model system for large-scale studies of
human reprogramming.
Genome-wide Profiling of Reprogramming Cells
We next leveraged the increased proliferative capacity and
decreased heterogeneity of hiF-Ts to collect large numbers of
cells for comprehensive immunophenotypic, genomic, and epi-
genomic analyses of reprogramming. hiF-Ts rapidly lost the so-
matic cell marker CD13 uponOKMS induction and then acquired
the embryonic marker SSEA-3. A subset of the most SSEA-3
positive cells subsequently acquired the pluripotency-associ-
ated marker TRA-1-60 (Figure 2A). We collected cells from key
stages throughout this process. In the most advanced stages,
we fractionated cells based on SSEA-3 or TRA-1-60 expression
to isolate those that were transitioning toward pluripotency (Fig-
ure 2B).We then profiledmRNA and small RNA byRNA-seq,ma-
jor histone modifications (H3K4me1, me2, me3; H3K27ac, me3;
H3K36me3) by chromatin immunoprecipitation sequencing
(ChIP-seq) and DNA methylation by reduced representation
bisulfite sequencing (RRBS).
To characterize the major transitions in cellular states during
reprogramming, we performed multi-dimensional scaling
(MDS) analyses on the resulting data (Figures 2C–2E).
MDS of the RNA-seq data revealed a continuous trajectory of
transcriptional changes beginning with uninduced hiF-Ts and
ending with established hIPSC-Ts (Figure 2C). Cells with higher
SSEA3 or TRA-1-60 expression were closer to the hIPSC-T state
than cells with lower expression at the same day (Figure S2A),
confirming the specificity of these surface antigens for reprog-
ramming cells. Notably, the expression patterns of transgene-
expressing TRA-1-60+ cells isolated at days 20–24 were clearly
distinct from those observed after DOX withdrawal and estab-
lishment of hIPSC-Ts, as well as from reference human embry-
onic stem cells (hESCs).
MDS of H3K4me2 (Figure 2D), a histone methylation mark
associated with open chromatin and active regulatory elements
(Zhou et al., 2011), suggested two major transitions in its distri-
bution: one occurring during the first 5 days and a second
coinciding with the acquisition of TRA-1-60. In contrast,
genome-wide DNA methylation patterns (Figure 2E) appeared
to remain largely constant throughout the first 14 days of theCell 162, 412–424, July 16, 2015 ª2015 Elsevier Inc. 413
Figure 1. An Optimized Secondary Reprogramming System for Human Reprogramming
(A) Schematic representation of secondary reprogramming strategy and hiF-T engineering using inducible reprogramming factors (iOKMS) under the control of
the reverse tetracycline transactivator (rtTA). Fibroblasts and IPSCs are shown as belonging to a primary hiBJ (blue), derived secondary hiF (green) and hiF-hTERT
(brown) reprogramming system.
(B) Alkaline phosphatase (AP) staining of the indicated reprogrammed cells.
(legend continued on next page)
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reprogramming course but then changed rapidly upon TRA-1-60
acquisition and again upon removal of DOX and derivation of
hIPSC-T lines, eventually reaching a pattern equivalent to that
of reference hESCs.
The different genome-wide profiles therefore all suggested
that TRA-1-60+ cells obtained at the end of the reprogramming
course were qualitatively different from both derived hIPSC-T
cell lines and reference hESCs when maintained under standard
culture conditions. In the following sections, we characterize
these differences and the preceding dynamics in more detail.
Ordered Re-activation of Developmental and
Pluripotency Pathways
Clustering analysis of the RNA-seq data identified ten major dy-
namic expression patterns (Figure 3A). We applied two comple-
mentary approaches to interpret these clusters: (1) a comparison
with gene expression signatures obtained from hESCs in their
undifferentiated state or upon differentiation toward the three
major germ layers; and (2) gene ontology enrichment analysis
for both biological processes and developmental cell identity
(Edgar et al., 2013) (Figure S2D; representative genes in Figures
3B and S2B).
Similar to murine reprogramming systems (Mikkelsen et al.,
2008; Polo et al., 2012), OKMS rapidly downregulated mesen-
chymal signature genes, including genes encoding structural
components, like collagen, and transcription factors, like
SNAI2 and FOSL1. We also observed rapid, but transient, down-
regulation of genes that are known to be expressed in both stem
cells and terminally differentiated cells, most notably the bHLH
Inhibitor of DNA-binding (ID) proteins. Pluripotency-related
genes were subsequently activated in two waves, distinguishing
early pluripotency signature genes already detected by day 5,
such as DPPA4, from late core regulators, like LIN28A that
were fully activated only in TRA-1-60+ cells at day 20. A final
set of genes reached maximal levels only after derivation of
hIPSC-T. This set included neuro-ectodermal and epiblast-
related factors like SOX3 and OTX2, likely reflecting a priming
of human PSCs under standard culture conditions (Tesar et al.,
2007).
While rapid downregulation of somatic genes and subsequent
activation of the pluripotency network have been described
(Chan et al., 2009; Park et al., 2008), comprehensive character-
ization of the transitions between these states has been limited
by the heterogeneity of previous reprogramming systems. We
found that the more synchronized changes of the hiF-T system
allowed us to characterize several transient waves of gene acti-
vation (last panel in Figure 3A).
The first transient wave peaked at day 5 and was enriched
for genes promoting proliferation and metabolic changes.
Genes characteristic of this wave included IGF2, AFP, GSN,(C and D) Representative bright fields of hiF and hiF-T cultures at different passage
assay and corresponding alkaline phosphatase (AP) staining after 24 days of rep
blue and indicated with dark arrows.
(E) Histograms showing absolute expression levels of selected proliferation, st
fragments per kilobase per million fragments mapped. Error bars represent a 95
respect to control BJ at false discovery rate (FDR) <1%.
(F) Hierarchical clustering of BJ, hiF, and hiF-T cells according to expression levand ALDH1A1, which are known to exert complementary prolif-
erative and/or anti-apoptotic functions. The second wave, which
peaked in the SSEA3+ fraction at day 10, included genes ex-
pressed during body patterning in late embryogenesis, such as
HOX genes (see also Figure 3B), as well as markers of devel-
oping mesoderm (e.g., H19) and endoderm (e.g., HNF transcrip-
tion factors). The third wave brought activation of genes associ-
ated with early embryogenesis and primitive endoderm,
including NANOG, UTF1, LEFTY2, NODAL, and GDF3. Similar
to murine reprogramming, NANOG activation reached its peak
prior to activation of the core pluripotency network (Sama-
varchi-Tehrani et al., 2010). Finally, and in parallel with activation
of the core pluripotency network in TRA-1-60+ cells around day
20, we detected substantial expression of pre-implantation- or
trophoblast-associated markers (e.g., DPPA2/3/5, DNMT3L,
ALPPL2, FGF4, and TFCP2L1) and lowly expressed primitive
streak genes (e.g., T, CER1, MIXL1). Notably, these markers
were lost upon withdrawal of DOX and derivation of clonal
hIPSC-T lines (e.g., DPPA3/STELLA [Hayashi et al., 2008] in
Figures 3B, 3C, and S3A). This is consistent with the final step
of hIPSC-T derivation from TRA-1-60+ colonies being accompa-
nied by a shift from a gene expression program with pre-implan-
tation-like characteristics to a programwithmore post-implanta-
tion-like characteristics (Figures S3B and S3C).
To examine whether the patterns we observed from bulk
RNA profiling actually reflected changes that occurred within in-
dividual cells, or were in fact averages over multiple distinct sub-
populations, we collected single cell RNA-seq profiles from 52
unfractionated hiF-T cells after 10 days of reprogramming (Fig-
ure 3D). We found low expression of genes from the previously
defined somatic cluster and high expression of genes from the
developmental clusters across the majority of the cells (Fig-
ure S3D). Notably, consistent with the bulk profiles, many of
the single cells displayed simultaneous expression of genes
associated with early and late embryogenesis, as well as
LIN28A and other pluripotency markers (Figures 3D and S3D).
To test whether the expression dynamics in hiF-Ts were repre-
sentative of other reprogramming systems, we also profiled non-
immortalized hiFs at multiple time points (Figure S2C). These
secondary cells were derived similarly to the frequently used
dH1f (Park et al., 2008). We found that all patterns described
above, including the late expression of pre-implantation-associ-
ated markers, also emerged from the hiFs, although with lower
magnitude. Our data therefore suggest a general model of
human OKMS-mediated reprogramming where cells first enter
a highly proliferative state and lose their somatic identity, then
display preferential re-activation of late, followed by early devel-
opmental genes, finally leading to the emergence of a distinct
transient expression program with pre-implantation-like charac-
teristics in the TRA-1-60+ subpopulation.s, after senescence-associated-beta-galactosidase (SA-b-GAL, upper panels)
rogramming (lower panels). Scale Bar, 100 mm. Senescent cells are stained in
emness, and senescence related genes, as measured by RNA-seq. FPKM,
% confidence interval around the average values. *Significant difference with
els of proliferation (left) or stemness-related (right) genes.
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Figure 2. Integrative Analysis of Human Cellular
Reprogramming
(A) Flow cytometry analysis of surface markers during
reprogramming of hiF-T cells.
(B) Schematic representation of time course collection
of reprogramming intermediates, including fractionation
by the indicated surface markers. For reprogramming,
hiF-T cells were seeded on MEF feeder layer (MEF).
Reprogramming was initiated at day 0 (DOX) and a
switch to KSR-hESC media was performed at day 2
(KSR). The collection point labeled 24* represents cells
reprogrammed for 20 days in DOX followed by 4 days
without DOX.
(C) MDS analysis of RNA-seq data (left) along with the
number of differentially expressed (DE) genes associ-
ated with each transition (right). More comparisons are
shown in Figure S2A.
(D and E) MDS analyses of epigenomic data from re-
gions differentially enriched (DE) in H3K4me2 or differ-
entially DNA methylated (DM).
In all the representations, samples are color coded to
the reference time points in (B).
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Figure 3. Transcriptional Dynamics during Human Cellular Reprogramming
(A) Line plots showing expression dynamics of differentially expressed genes during reprogramming, grouped by k-medoids clustering. Refer to Figure 2B for re-
programming time points. Gray shades represent a 95%bootstrap confidence interval around themedian values. For each cluster, the median expression value in
hESCusing18 referencehESC lines is also reported.Heatmapsbeloweachset of clusters (upregulated, downregulated, and transients) show the total expression of
genes in each cluster with respect to gene sets that define pluripotent (hESC) or embryonic germ layer-specific cells (ECTOderm, ENDOderm, MESOderm).
(B) Absolute expression levels (FPKM) of selected dynamic genes reported as line plot or heatmap.
(C) Representative colony of reprogrammed hIF-T cells identified by TRA-1-60 chromogenic staining in bright field and overlapping UTF1 and DPPA3 fluorescent
staining. Complete field and staining controls are reported in Figure S3A.
(D) Co-expression relationships between representative markers of the identified developmental transitions with respect to LIN28A as reference pluripotent
marker, measured by single-cell RNA-seq. Additional single-cell data are shown in Figure S3D.
(E) Absolute expression levels of categorized miRNAs (as normalized counts; see Experimental Procedures) (upper panel) and the relative expression levels of
specific miRNA families with respect to total miRNA abundance (lower panel) at the indicated time points and in hESC line HUES64.
(F) Line plot showing absolute expression values of mRNA and miRNA involved in MET during reprogramming and in reference hESCs. Pluripotent genes with
different onset during reprogramming (LIN28A, NANOG, TET1) are also included to illustrate the relationship between epithelialization and acquisition of
pluripotency.
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Analysis of miRNA captured in the small RNA-seq data (Fig-
ure 3E) reinforced this model. We similarly observed the rapid
loss of somatic miRNAs (e.g., the miR-221 family), followed by
upregulation of miRNAs under developmental control (e.g.,
miR-10) and eventually of pluripotency-associated families (the
miR-371 cluster and the miR-302 family). Strikingly, while many
different miRNA families were expressed at comparable levels
in hiF-Ts, each phase of the reprogramming process was
defined by only one specific miRNA family that alone accounted
for almost 50% of the sequenced molecules from that phase.
Notably, miR-10b alone represented 49% of total miRNAs
sequenced during the reactivation of late mesoderm pathways,
which is consistent with its location within the HOXD cluster
that is activated during this phase. The miR-371 cluster ac-
counted for the majority of the mature miRNAs in TRA-1-60+
cells after day 20, while the miR-302 family, which is enriched
in the post-implantation mouse embryo (Parchem et al., 2014),
dominated in derived hIPSC-Ts. Consistent with neuro-ecto-
dermal priming, derived hIPSC-Ts also expressed higher levels
of miRNAs associated with neuronal progenitors (e.g., members
of miR-25 family) (Nowakowski et al., 2013).
A possible driver of the differences in gene expression be-
tween TRA-1-60+ cells in DOX-containing media and derived
hIPSC-Ts is elevated expression of KLF4 in the former. While
the combined expression levels of the lentiviral and endogenous
OCT4, SOX2, and c-MYC genes were largely similar, KLF4
expression was 100-fold higher in the TRA-1-60+ cells (Fig-
ure S2B). This would be consistent with recent reports that
higher expression of KLF proteins can push IPSC colonies to a
more pre-implantation-like state (Gafni et al., 2013; Takashima
et al., 2014).
Interestingly, while a mesenchymal to epithelial transition
(MET) has been reported as a critical early event in reprogram-
ming of mouse cells (Li et al., 2010; Samavarchi-Tehrani et al.,
2010), we did not observe clear enrichment of epithelial associ-
ations in the early phases of hiF-T reprogramming in our gene
ontology analysis. We therefore looked specifically for the acti-
vation of key epithelial marker genes (Figure 3F). In mouse cells,
activation of these markers precedes activation of Nanog
and the core pluripotency network (Samavarchi-Tehrani et al.,
2010). In contrast, during hiF-T reprogramming, these markers
appeared to be activated at the same time as NANOG,
LIN28A, TET1, and other core regulators of pluripotency.
A Pre-implantation-like Chromatin State Is Transiently
Established during Reprogramming
A characteristic feature of pluripotent cell lines is that the pro-
moters of many developmental regulatory genes display a biva-
lent chromatin state, where histone marks associated both with
activation (H3K4me2/me3) and repression (H3K27me3) co-
occur (Zhou et al., 2011). To study the acquisition of bivalency
during hiF-T reprogramming, we focused on 6,615 promoters
that showed a significant change in either H3K4me3 or
H3K27me3 signal between day 0 and the iPSC state (Figures
4A and 4B). As expected, bivalent promoters were rare at the
somatic and early stages. The reprogrammed TRA-1-60+ sub-
population at 24 days displayed a significant number of bivalent
promoters, but only approximately half of that found in clonal418 Cell 162, 412–424, July 16, 2015 ª2015 Elsevier Inc.hIPSC-Ts derived from them. Interestingly, other groups have
recently reported that an increase in bivalency is a key feature
of the transition between naive and primed states in ESCs (Marks
et al., 2012; Theunissen et al., 2014), although the extent to
which this reflects epigenetic changes occurring during human
embryogenesis remains unknown.
The distinction between TRA-1-60+ cells and established
hIPSC-T was, however, further clarified by analysis of promoter
DNA methylation. Consistent with the genome-wide MDS anal-
ysis (Figure 2E), we found that the vast majority of changes in
promoter DNA methylation took place during the late stages of
reprogramming (Figures 2E and 4C). A comparison of our data
with methylation profiles from human blastocysts and reference
hESCs (Smith et al., 2014) allowed us to identify 722 differentially
methylated promoters that each followed one of three major pat-
terns: (1) promoters with highmethylation in fibroblasts that were
hypomethylated in all reprogrammed or pluripotent samples
(24 days TRA-1-60+ cells, derivative hIPSC-T, in vivo blastocysts
and in-vitro derived hESCs); (2) promoters with low to moderate
methylation in fibroblasts that became hypermethylated upon
hIPSC-T derivation were also hypermethylated in hESCs but
showed lower methylation in both 24 days TRA-1-60+ cells and
blastocysts; and (3) hypermethylated promoters that were tran-
siently de-methylated in 24 days TRA-1-60+ cells showed low
methylation in blastocysts but hypermethylation in both hIPSC-
Ts and hESCs. This third pattern included promoters of key
pre-implantation markers, such as DNMT3L, DPPA3, and miR-
371. Although we did not observe global DNA hypomethylation,
the differences in promoter DNA methylation between TRA-1-
60+ cells at 24 days of reprogramming and derived hIPSC-Ts
are in agreement with those previously described between
human pre-implantation blastocyst and derived hESCs (Smith
et al., 2014).
Transient Chromatin Remodeling at Lineage-Specific
Regulatory Elements
To corroborate our finding that OKMS transiently re-acti-
vates diverse developmental pathways prior to acquisition of
pluripotency, we next examined changes in H3K4me2, a histone
methylation mark associated with both active promoters and
enhancers (Zhou et al., 2011).
We detected altered H3K4me2 levels in 26,122 distinct
genomic regions throughout hiF-T reprogramming. These re-
gions could be grouped into 14 dynamic clusters (Figures 5A,
S4A, and S4B). 4,815 regions (clusters 1 and 2) displayed
H3K4me2 in hiF-Ts but lost this mark within 5 days of OKMS in-
duction. 8,794 regions (clusters 9–14) were unmarked until day
10 or later, with clusters 10 and 12 showing maximal signals
only after derivation of hIPSC-Ts. The remaining 12,513 regions
(clusters 3–8) showed variable patterns of transient H3K4me2,
many with maximal signal at day 5.
Comparing these dynamic H3K4me2 patterns to reference
chromatin maps from various human cell types and tissues (Kun-
daje et al., 2015) (Figure 5A), we found that regions that were
marked by H3K4me2 in hiF-T cells but rapidly lost this mark
upon OKMS induction were largely specific to in-vitro-derived
somatic cell lines. Regions that gained H3K4me2 during the early
stages of reprogramming often displayed active chromatin
Figure 4. Changes in Bivalency and DNA Methylation during Reprogramming
(A) Chromatin state maps of 6,615 dynamic promoter regions, showing active (H3K4me3), repressed (H3K27me3), or bivalent regions (functionally poised by the
co-enrichment of both H3K4me3 and H3K27me3). Promoters with none of these histone marks are marked by different degrees of DNA methylation (DNAme,
three shades of gray for the ranges 25%–50%, 50%–75%, and 75%–100%).
(B) Histone methylation at representative 5- to 50-kb loci from the major transcriptional clusters in Figure 3B. A similar map of the broad pre-implantation region
around the miR-371 cluster is also reported in Figures S4C and S4D.
(C) Violin plots showing promoter DNAmethylation dynamics across the indicated reprogramming time points and sample types, grouped by k-means clustering.
n, size of each cluster. The box plots show the first and the third quartiles, along with the medians.marks in tissues of both mesodermal and ectodermal origin,
while regions that gained H3K4me2 in the late stages often
also display active chromatin marks in tissues of endodermal
origin. We therefore conclude that the transient activation of
developmental pathways during reprogramming is accompa-
nied by chromatin remodeling at regulatory elements associated
with lineages of different developmental stages.
OKMS Induction Supports Direct Lineage Conversion
The transient re-activation of developmental pathways and reg-
ulatory elements suggested to us that OKMS expression might
induce epigenetic changes that could enable direct reprogram-
ming to alternative lineages in addition to pluripotency. In sup-
port of this, using the Transcription factor Epigenetic Remodel-
ing Activity (TERA) framework (Ziller et al., 2015), we found that
the DNA sequences of genomic regions showing changingH3K4me2 were associated with potential binding sites for
numerous transcription factor families involved not only in plurip-
otency, but also in developmental patterning and differentiation
(Figures 5B and S5).
The TERA analysis revealed that regions that gained H3K4me2
at early time points frequently coincided with OCT4 and SOX2
binding sites, which is consistent with a more dominant role for
these transgenes in chromatin remodeling during the early
stages of reprogramming relative to the late stages of IPSC
establishment (Soufi et al., 2012). In contrast, regions that gained
H3K4me2 at later time points were enriched for potential binding
sites for other transcription factors that were upregulated toward
the end of the time course, such as ZIC3 andREST. In agreement
with our previous analyses, the transient waves of develop-
mental gene expression were accompanied by exposure of
binding sites for transcription factors acting in fetal developmentCell 162, 412–424, July 16, 2015 ª2015 Elsevier Inc. 419
Figure 5. Transient Chromatin Remodeling and Epigenetic Priming during Reprogramming
(A) Left: heatmap showing the Z scores of the mean H3K4me2 enrichment in 26,122 dynamic genomic regions, grouped into 14 clusters. For full representation of
the clusters and corresponding H3K27me3 dynamics refer to Figures S4A and S4B. Right: heatmap showing the corresponding z-scores of the mean H3K27ac
enrichment across tissues of different identity.
(B) Heatmap showing the TERA score of selected transcription factors predicted to be activated during the indicated reprogramming transitions, based on
H3K4me2 footprints. Corresponding absolute gene expression values (FPKM) during reprogramming are reported on the right. A full list of the top transcription
factors groups and their predicted co-binding relationships are shown in Figure S5.
(C) Bar plot showing the cumulative absolute expression values (FPKM) of the ID gene family during reprogramming.
(D) Schematic representation of the OKMS-enhanced MYOD reprogramming of hiF-Ts.
(E) Representative field of MYOD-mediated myogenic conversion without (–DOX) or with (+DOX) prior OKMS activation for 3 days. Cells positive for ectopic
FLAG-MYOD are green while cells positive for the late muscle marker MHC are red. The corresponding MHC whole-well staining is shown in the corner of each
condition. Scale Bar, 200 mm.
(F) Bar plot showing the normalized cumulative expression counts of pluripotent (SOX2, NANOG, POU5F1) and muscle -specific genes (CKM, muscle creatine
kinase; MYOG, myogenin; endoMYOD, endogenous MYOD). Controls are reference PSCs, hiF-T reprogramming time points, and differentiated human skeletal
muscle myoblasts (HSMM).like HOXD13 and PBX1. Interestingly, some factors which bind-
ing sites were also enriched in transiently H3K4me2-marked re-
gions, including bHLH transcription factors MYOD, NEUROD2,
and OLIG2, were not detected by RNA-seq at any time point.
This enrichment might therefore reflect lineage priming by other
factors. In addition, we noticed that OKMS induction led to a
transient downregulation of the ID transcriptional repressor fam-
ily (Figure 5C), which are known to restrict lineage commitment
by inhibition of bHLH activity (Perk et al., 2005).
To test our hypothesis of epigenetic priming toward alternative
fates, we performed ectopic expression of MYOD, a master
regulator of skeletal muscle cell fate. MYODwas first discovered
as a factor that reprogrammed somatic cells toward a myotube
fate (Fong and Tapscott, 2013), although the efficiency of this
phenomenon differs across cell types (including fibroblasts sub-420 Cell 162, 412–424, July 16, 2015 ª2015 Elsevier Inc.types; Salvatori et al., 1995), due to variation in epigenetic states
and expression of inhibitors such as ID1 (Perk et al., 2005). We
found that introduction of a MYOD lentivirus led to a very low
rate of myogenic conversion of otherwise unperturbed hiF-T
cells, as judged by low expression of skeletal muscle markers
at both the protein andmRNA levels (Figures 5D–5F). In contrast,
introduction of MYOD after a 3-day pulse of OKMS expression
drove efficient conversion to myosin heavy chain (MHC) positive
cells and induced key muscle genes to levels that approached
those of mature skeletal muscle cells within another 3 days.
Notably, introduction of MYOD after OKMS induction uniquely
activated endogenous MYOD, which may support stabilization
of the converted state through its auto-regulation (Hanna et al.,
2010). The rapid rate of conversion and the complete absence
of pluripotency markers throughout the time course (Figure 5F)
Figure 6. Characterization of Negative Regulators of Reprogramming
(A) Schematic representation of the pooled shRNA screening strategy.
(B) Scatter plot showing comparison of selected reprogramming efficiencies in shRNA-perturbed hIF-T cells at day 15 in a pooled screening format (y axis,
enrichment of shRNA sequence reads from TRA-1-60+ cells versus cells prior to induction of reprogramming) versus an arrayed format (x axis, area of TRA-1-60+
colonies). The reported values are the mean of biological duplicates.
(C) Bar plots showing reprogramming efficiency (number of TRA-1-60+ colonies) upon shRNA-mediated perturbation of candidate regulators (upper histogram)
and the corresponding change in mRNA expression levels in hIF-T cells relative to the effect of a control shRNA targeting luciferase (LUC) mRNA (lower his-
togram). Additional controls are shRNAs targeting GFPmRNA or uninfected cells. Three distinct hairpins were tested for each gene and representative TRA-1-60
stainings for each shRNA group are displayed above each set (control lane shows wells of both shGFP and shLUC treatments). Similar effects were observed
in primary BJ reprogramming experiments, as shown by TRA-1-60 stainings below each set. Error bars indicate SD from the average. All reported values in
histograms are significant with respect to controls at FDR <5%. *Significant difference with respect to control at FDR <1%. Representative TRA-1-60 staining at
indicated time points of hiF-T reprogrammed in the continuous presence of the indicated inhibitors.
(D) Gene expression profiles, from RNA-seq, of hiF-T reprogramming with or without LSD1 inhibition (LSD1i and CTRL respectively), represented as points in
two-dimensional MDS component space. A gene set enrichment analysis is described in Figure S6C.
(E) Heatmap showing expression (normalized z-score) of indicated genes during reprogramming in different conditions (untreated control, LSD1 inhibition, ROCK
inhibition). Key time points for reprogramming transitions are indicated (0, 4, 8, 12). Corresponding MDS plot of the RNA-seq time course utilized to identify these
genes is reported in Figure S6D.strongly suggest that it did not involve transition through an inter-
mediate pluripotent state. We therefore conclude that OKMS
rapidly drives cells into an epigenetic state that is conducive
not only to derivation of pluripotent cells, but also to direct con-
version into alternate lineages.
Identification of Regulatory Genes that Inhibit
Reprogramming
Wenext attempted to identify regulatory factors thatmight inhibit
or delay reprogramming to pluripotency. We again leveraged the
expansion capacity and uniformity of hiF-Ts to perform a quan-
titative RNAi screen (Luo et al., 2008) using a pooled lentiviral
library encoding 2,900 small hairpin RNAs (shRNAs) targeting
370 distinct regulatory genes with known or putative roles
in chromatin remodeling and other epigenetic processes. The
library complexity was chosen to maximize the representation
of neutral shRNAs in the final TRA-1-60+ population despite
the bottleneck imposed by limited reprogramming efficiency
(see Experimental Procedures).We noted that hiF-T cultures infected with the lentiviral pool
generated TRA-1-60+ colonies much more efficiently than con-
trols. To identify the genes for which knockdown led to enhanced
reprogramming, we compared shRNA abundances before
(hiF-T) and after (TRA-1-60+) reprogramming using deep
sequencing (Figure 6A). This primary screen identified 23 candi-
date genes with at least one strongly enriched hairpin. In a sec-
ondary screen, we confirmed seven of these candidates (EZH1,
KTI12, LBR, NAP1L3, RSF1, SHPRH, and LSD1) based on
consistent phenotypes from three distinct shRNAs (Figure 6B).
The majority of the validated regulators have not been well char-
acterized, but they span a variety of different chromatin modifi-
cation and remodeling processes. Six of the seven have to our
knowledge not been reported as barriers to human reprogram-
ming (Onder et al., 2012). The positive effect of inhibiting the Pol-
ycomb complex member EZH1 is surprising given that its homo-
log EZH2 is required for reprogramming (Onder et al., 2012), but
we note that the two appear to regulate different targets (Shen
et al., 2008). Inhibition of the histone lysine demethylase LSD1Cell 162, 412–424, July 16, 2015 ª2015 Elsevier Inc. 421
(KDM1A) has been reported to enhance reprogramming (Li et al.,
2009), but its mode of action remains unknown.
Comparison of theEffects of LSD1andROCK1 Inhibition
on Reprogramming
As LSD1 was the only validated hit in our RNAi screen with avail-
able chemical inhibitors, we sought study the effects of its
perturbation in more detail. We found that inhibition of LSD1
with either a standard inhibitor (parnate) or a potent analog
(Histone Lysine Demethylase Inhibitor RN-1; Neelamegam
et al., 2012) dramatically enhanced hiF-T reprogramming. A
10-nM dose of RN-1 over the first 5 days was sufficient to both
accelerate and increase the efficiency of reprogramming
(Figure S6A), generating TRA-1-60+ cells in less than 10 days
(Figure 6C), as opposed to at least 15 days in untreated cultures.
This effect was higher than the previously reported effect of
ROCK1 inhibitor Y-27632, which also requires much higher con-
centrations (R1 mM). In addition, chemical inhibition of LSD1
enhanced reprogramming even in the presence of saturating
doses of the ROCK1 inhibitor (Figure S6B), which suggests syn-
ergistic modulation of distinct pathways.
Notably, TRA-1-60+ cells from LSD1i-treated cultures at day
13 were indistinguishable from those from untreated cultures
from day 20, as judged by RNA-seq profiling (Figure 6D), and
could be used to generate stable hIPSC-T clones. The efficiency
of hIPSC-T derivation from LSD1i-treated cells was significantly
higher than that of ROCK1i-treated cells, which indicates
more consistent and complete reprogramming (Figure 6C, lower
panel). Moreover, the accelerated reprogramming caused by
LSD1 inhibition did not appear to simply be a result of increased
proliferation or decreased apoptosis (Figure S6C), as has been
suggested for ROCK1 inhibition (Watanabe et al., 2007). On
the contrary, the replication rate of LSD1i-treated hiF-T is not
affected in short-term cultures.
To gain deeper insights into the effects of LSD1 and ROCK1
inhibition, we collected additional data from each of the first
12 days of a new reprogramming experiment with LSD1i- and
ROCK1i-treated and -untreated hiF-T cells using RNA-seq. We
were particularly interested in whether the gene expression
changes in the treated cells followed the same trajectory as un-
treated cells. MDS analysis suggested that this was indeed the
case (Figure S6D). Both LSD1i and ROCK1i treatments led to
the similar patterns of rapid downregulation of somatic genes,
followed by transient upregulation of various developmental
and embryonic genes. The expression of early and late markers
of pluripotency, such as NANOG and LIN28A, were not acceler-
ated with respect to the control cells in early time points, but they
became significantly upregulated with respect to untreated cells
by day 8 (Figure 6E).
Interestingly, the only significant change in gene expression
unique to LSD1i-treated cells in the early stages of the reprog-
ramming was an accelerated upregulation of a small set of genes
enriched in epithelial markers, most notably e-cadherin (CDH1),
EPCAM, KRT19, and CLDN10. CDH1 is known to be both a
major driver of the MET process and essential for maintenance
of the pluripotent state (Samavarchi-Tehrani et al., 2010). In
fact, CDH1, EPCAM, and KRT19 are among the most highly
expressed epithelial genes in human PSCs (data not shown).422 Cell 162, 412–424, July 16, 2015 ª2015 Elsevier Inc.This suggests that LSD1 inhibition may enhance reprogramming
through epithelialization, a phenomenon that we found to be
delayed under standard conditions (see Figure 3F).
In contrast, the ROCK1i treatment was characterized by
elevated and persistent expression of growth promoting genes
like IGF2 and ALDH1A1 during the later stages (Figure 6E). This
is consistent with increased proliferation and survival but could
also explain the lower efficiency of hIPSC-T derivation from
ROCK1i-treated cells (Figure 6C, lower panel). IGF2 andALDH1A
has both been found to be highly expressed in cancer stem cells
(Baccelli and Trumpp, 2012; Pollak, 2008) and persistent IGF2
expression has recently been reported as amaker of transforma-
tion in vivo during cellular reprogramming (Ohnishi et al., 2014).
This indicates that prolonged ROCKi treatment may favor the
emergence of a highly proliferative and potentially aberrant
reprogramming environment.
DISCUSSION
Ever since the first successful attempts to reprogrammouse and
human cells were reported (Takahashi and Yamanaka, 2006), it
has been clear that there are significant species-specific differ-
ences in these processes. The hiF-T secondary reprogramming
system now provides a convenient and representative model
system for dissection of reprogramming in human cells.
Recent work by Yamanaka and colleagues has shown that
reprogramming human cells enter into an early mesendodermal
state just prior to acquisition of pluripotency (Takahashi et al.,
2014). Extending this observation, we found evidence of multiple
transient waves of gene expression changes that begin with a
rapid loss of somatic identity, followed by re-activation of early
developmental pathways and embryonic patterning genes in
the reverse order of normal development, eventually reaching a
pre-implantation-like state that is only lost upon derivation of
IPSC lines under standard conditions.
In fully committed somatic cells, the reprogramming factors
appear to facilitate re-activation of related developmental line-
ages that reflect their ontology. Thus, fibroblast-like hiF-T cells
largely de-differentiate to first express a broad mesodermal
signature and then features of early development. We hypothe-
size that somatic cells of different origins might activate different
transient gene sets. Eventually, only a small fraction of those
cells will activate the core pluripotency network. A key remaining
question is whether passing through either one of these transient
cell states is strictly required for successful derivation of human
IPSC lines.
Several recent studies have argued that human PSCs can be
brought into a more naive state of pluripotency with cocktails
of chemical inhibitors and/or transcription factors (Gafni et al.,
2013; Takashima et al., 2014; Theunissen et al., 2014). Our
data show that OKMS expression alone is sufficient to induce
key mRNA and miRNA genes that are uniquely expressed in
the pre-implantation embryo, and to reduce DNA methylation
of promoters that are known to be hypomethylated in the inner
cell mass but hypermethylated in standard hESC cultures. We
also show that prior to reaching the stabilized pluripotent state,
OKMS expression induces a less restricted epigenetic state
that is particularly amenable to direct lineage conversion. This
is consistent with recent reports of derivation ofmesodermal and
endodermal cell types from the early stages of reprogramming
cell populations (Efe et al., 2011; Zhu et al., 2014).
We expect that the consistency and virtually unlimited expan-
sion potential of the hIF-T system will enable new approaches to
dissection of human cellular reprogramming.
EXPERIMENTAL PROCEDURES
Cell Culture and Reprogramming
Human fibroblasts were cultured in an optimized DMEM/F12 culture media
supplemented with 10% FBS. Pluripotent stem cells were cultured in 20%
knockout serum replacement (KSR)-based DMEM/F12 culturemedia with irra-
diated MEF feeders or mTeSR1 or Essential 8 media without feeders. Reprog-
ramming was performed on a confluent irradiated MEF layer using the KSR
media formulation and doxycycline as indicated. BJ fibroblasts were first re-
programmedwith a dox-inducible, polycistronic OKMS lentiviral vector (Addg-
ene 51543). This gave rise to the first hIPSC line, which was then differentiated
in vitro (Park et al., 2008) to obtain the hiF line. Infection of the hiF line with a
CMV-hTERT lentivirus (Applied Biological Materials) and clonal isolation
generated the final hiF-T. Directed differentiation of hIPSC-T was performed
as previously reported (Gifford et al., 2013). Additional details of cell culture
and media formulations, reprogramming, and sampling are reported in the
Supplemental Experimental Procedures.
Cellular Assays
Senescence (beta-galactosidase), alkaline phosphatase, flow cytometry, and
immunostaining analyses were performed with commercial kits and anti-
bodies, as detailed in the Supplemental Experimental Procedures. Cell prolif-
eration, senescence, and apoptosis during fibroblasts expansion and reprog-
ramming efficiency were assessed using manual cell or colony counting as
indicated. For quantitative analysis of reprogramming efficiency in some
comparative approaches (RNAi screening, LSD1, and ROCK1 inhibition), dig-
ital acquisition of chromogenic TRA-1-60 staining was performed and followed
by colony identification and counting by ImageJ (http://imagej.nih.gov/ij/).
Further details are reported in Supplemental Experimental Procedures.
Genomic and Epigenomic Profiling
Cells were prepared for profiling using MEF depletion and, in some instances,
SSEA-3 or TRA-1-60 enrichment/depletion using magnetic beads separation
(Miltenyi Biotec) as indicated in the text. Bulk mRNA-seq and small RNA-seq
were performed using TruSeq kits (Illumina). Single cell RNA-seq was per-
formed using the Smart-Seq2 protocol with minor modifications. RRBS and
ChIP-seq were performed as previously described (Mikkelsen et al., 2010;
Boyle et al., 2012). Assessment of MYOD-mediated direct differentiation
was performed using a NanoString nCounter with a custom codeset. High-
throughput 30 digital gene expression (DGE) was performed using a modified
single-cell RNA barcoding sequencing (SCRB-seq) protocol with barcoded
poly-dT RT primers and a hybrid Nextera/TruSeq sequencing strategy. Details
of all the library construction and sequencing procedures as well as down-
stream bioinformatics analyses are reported in Supplemental Experimental
Procedures.
RNAi Screening
RNAi screening was performed by infecting at least 6 3 107 hiF-T cells with a
pool of The RNAi Consortium (TRC) lentiviral shRNA constructs targeting 370
distinct epigenetic regulators and then reprogramming the infected cells for
15 days. Integrated shRNA templates were recovered from TRA-1-60+ cell
gDNA by PCR and counted using Illumina sequencing. Further details are
reported in Supplemental Experimental Procedures.
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